NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
52,515,653
Share change
+2,567,720
Total reported value
$84,544,619
Put/Call ratio
12231%
Price per share
$1.61
Number of holders
76
Value change
+$4,133,792
Number of buys
35
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q2 2015

As of 30 Jun 2015, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,515,653 shares. The largest 10 holders included Platinum Management (NY) LLC, Commerzbank Aktiengesellschaft /FI, SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, BlackRock Fund Advisors, STATE STREET CORP, UBS Group AG, NORTHERN TRUST CORP, and BlackRock Institutional Trust Company, N.A.. This page lists 76 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.